Strategy & Corporate DevelopmentEvent: September 2, 2026
Nicox has financed its current operational structure into early 2028 and potentially into and beyond 2029 to provide a stable foundation for future development.
Published
Signal category
Strategy & Corporate Development
Quote
“we now have our current operational structure financed into early 2028, and potentially into, and beyond, 2029”
— Gavin Spencer|Nicox team
Company
Nicox
Maintain vision and improve ocular health
- Industry
- Pharmaceutical Manufacturing
- Location
- Valbonne, FR
- Company size
- 44 employees
Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com
Founded 1996